Thermo Fisher Scientific Inc. and Groupe Novasep SAS, a leading supplier of services and technologies for the life scien...
Samsung Biologics set forth its dynamic growth plan for the next decade at the 2021 Annual JP Morgan Healthcare Co...
FUJIFILM Corporation is making an investment of more than 200 Billion yen ($2 Billion) to establish a new...
Japanese firm Sosei Group Corporation has announced that it has entered into a global collaboration and license agr...
Japanese firm Sosei Group Corporation has announced that it has entered into a global collaboration and license agr...
Samsung Biologics has officially begun construction of its Plant 4 in Incheon, South Korea. Dubbed the "Super Plant...
South Korea based Samsung Biologics' partnership with Eli Lilly and Company is expected to greatly accelerate the global...
Merck has announced a strategic technology collaboration with Transcenta, a global biotherapeutics company headquartered...
China's Porton Biologics is committed to building an end-to-end gene and cell therapy CDMO service platform. The Op...
Thermo Fisher Scientific and Symphogen, an affiliate of and the antibody center of excellence within the international p...
Merck has recently announced a collaboration with Mammoth Biosciences Inc. of South San Francisco, California, USA, for ...
Avidity Science, a leader in water purification and delivery, control and monitoring and service solutions for the ...
TUV Rheinland, a global leader in independent technical services on 23 Oct 2020 announced the opening of its Biomaterial...
Samsung Biologics has entered into a partnership agreement with BioEleven to develop and manufacture BN-101A, a third-ge...
Singapore's Rockwell Automation on 15 Oct 2020 released the PlantPAx® 5.0 distributed control system (DCS). Thi...
Malaysia's Solution Biologics Sdn Bhd (SOLBIO), a subsidiary of Solution Group Bhd, has inked a deal with China based Ca...
Japan's Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development a...
Samsung Biologics has entered into a service agreement with Panolos Bioscience to develop PB101, an Fc-fusion protein in...